Mercado global de anemia na gravidez – Tendências do setor e previsão para 2028

Análise de mercado e insights: mercado global de anemia na gravidez

Espera-se que o mercado da anemia na gravidez ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 4,80% no período de previsão da pesquisa acima mencionado . Aumento de casos de hemodiluição durante a gravidez e aumento da população de mulheres grávidas durante a COVID-19, entre outros.

A elevada procura por novas opções de tratamento e diversos lançamentos de produtos também impulsionam o crescimento do mercado. Além disso, o aumento da parceria e colaboração entre os participantes do mercado e o apoio governamental favorável para uma melhor saúde das mulheres funcionam como uma oportunidade para o crescimento do mercado. No entanto, a presença de produtos fitoterapêuticos alternativos e de diretrizes regulamentares rigorosas podem dificultar o mercado global da anemia na gravidez .

A anemia na gravidez é caracterizada por poucos glóbulos vermelhos entre as mulheres, o que resulta numa baixa presença de oxigénio nas mulheres que sofrem. Esta falta de oxigénio afeta as atividades dos nervos e do tecido muscular e, portanto, afeta, em última análise, os processos gerais do corpo. Além disso, durante a gravidez, o feto em desenvolvimento também requer sangue eficiente, o que torna a mãe anémica se não for fornecida dieta e suplementos adequados. A presença de uma população feminina vegetariana estrita apresenta um maior risco de anemia na gravidez e, por isso, depende fortemente de outros produtos suplementares para satisfazer as necessidades corporais. Os sintomas comuns associados à anemia na gravidez incluem pele pálida, cansaço, dificuldade de concentração, taquicardia, dificuldade respiratória, entre outros. A anemia na gravidez pode ser tratada com a toma de citrato de amónio ferroso, sulfato de ferro ferroso, ferro dextrano, multivitamínico, derivados do ácido fólico, entre outros.

De acordo com o relatório da OMS, aproximadamente 40% das mulheres grávidas em todo o mundo são anémicas, o que depende de suplementos e medicamentos para satisfazer a contagem de glóbulos vermelhos e, por isso, espera-se que proporcionem ao mercado um crescimento rentável.

This pregnancy anemia market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Pregnancy Anemia Market Scope and Market Size

Pregnancy anemia market is segmented on the basis of type, treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the pregnancy anemia market is segmented into iron-deficiency anemia, folate-deficiency anemia, vitamin B12 deficiency.
• On the basis of treatment, the pregnancy anemia market is segmented into folic acid supplements, iron supplement, others.
• On the basis of end-users, the Pregnancy anemia market is segmented into clinics, hospitals, homecare, others.
• On the basis of distribution channel, the Pregnancy anemia market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others. 

Pregnancy Anemia Market Country Level Analysis

Pregnancy anemia market is analysed and market size information is provided by country, type, treatment,  end-users and distribution channel as referenced above.

The countries covered in the Pregnancy anemia market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to rising trend of smoking among women population who are at higher risk of pregnancy anemia and increase in number of healthcare facilities providing quality healthcare services. Europe accounts the second largest market share second largest market share due to increasing awareness about reproductive health among the public and increasing collaboration and partnership for development of novel therapies.  Asia-Pacific is expected to account for the largest market share over coming years for the Pregnancy anemia market due to increasing research and developmental activities for development of novel therapies and increasing investment for development of advanced manufacturing facilities.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Pregnancy anemia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Pregnancy Anemia Market Share Analysis

Pregnancy anemia market competitive landscape provides details by competitor, details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Pregnancy anemia market.

Os principais players abrangidos no mercado da Anemia na gravidez são a Spirochem Lifesciences Pvt Ltd., a Vifor Pharma Management Ltd., a AMAG Pharmaceuticals, a Fresenius SE & Co. KGaA, a Akebia Therapeutics, a CHO-A Pharmaceutical Co., Ltd., a LUPIN, a Orion Pharma Ltd. , SHIELD THERAPEUTICS, Sanofi, Teva Pharmaceutical Industries Ltd., Advanz Pharmaceutical, GlaxoSmithKline plc., Alkem Labs., Hikma Pharmaceuticals PLC, Avion Pharmaceuticals LLC, Allergan, Gland Pharma Limited, PHARMACOSMOS A/S entre outros players nacionais e globais. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-60278